908 Devices Inc (MASS)
7.85
-0.39 (-4.73%)
USD |
NASDAQ |
Mar 28, 15:10
908 Devices Cash from Financing (TTM): 1.179M for Dec. 31, 2022
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 1.179M |
September 30, 2022 | 95.30M |
June 30, 2022 | 95.61M |
March 31, 2022 | 95.42M |
December 31, 2021 | 94.72M |
Date | Value |
---|---|
September 30, 2021 | 137.38M |
June 30, 2021 | 136.90M |
March 31, 2021 | 136.62M |
December 31, 2020 | 137.19M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.179M
Minimum
Dec 2022
137.38M
Maximum
Sep 2021
103.37M
Average
95.61M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.084M |
Xtant Medical Holdings Inc | 9.02M |
Asensus Surgical Inc | -0.332M |
Ra Medical Systems Inc | 18.30M |
Retractable Technologies Inc | 15.80M |